Cargando…

Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity

BACKGROUND: Aarogyavardhini Vati is a classical Ayurvedic herbomineral formulation. It contains mercury and copper compounds as principal minerals along with other minerals and herbal ingredients. Aarogyavardhini Vati is indicated in chronic liver ailments. However, safety concerns are often raised...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamadagni, Shrirang, Jamadagni, Pallavi, Angom, Binita, Mondal, Dhirendranath, Upadhyay, Sachchidanand, Gaidhani, Sudesh, Hazra, Jayram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772489/
https://www.ncbi.nlm.nih.gov/pubmed/32035767
http://dx.doi.org/10.1016/j.jaim.2019.09.005
_version_ 1783629882242105344
author Jamadagni, Shrirang
Jamadagni, Pallavi
Angom, Binita
Mondal, Dhirendranath
Upadhyay, Sachchidanand
Gaidhani, Sudesh
Hazra, Jayram
author_facet Jamadagni, Shrirang
Jamadagni, Pallavi
Angom, Binita
Mondal, Dhirendranath
Upadhyay, Sachchidanand
Gaidhani, Sudesh
Hazra, Jayram
author_sort Jamadagni, Shrirang
collection PubMed
description BACKGROUND: Aarogyavardhini Vati is a classical Ayurvedic herbomineral formulation. It contains mercury and copper compounds as principal minerals along with other minerals and herbal ingredients. Aarogyavardhini Vati is indicated in chronic liver ailments. However, safety concerns are often raised regarding the use of mercury containing ayurvedic drugs in disease conditions due to the risk of mercury and copper toxicity. OBJECTIVE: This study was performed to address the safety concerns regarding mercury and copper toxicity from Ayurvedic herbomineral formulations by investigating accumulation of these minerals in tissues and subsequent toxicity in chronic hepatotoxicity rat model. MATERIALS AND METHODS: Quantification of mercury and copper in Aarogyavardhini Vati was done. Chronic hepatotoxicity was induced in the Wistar rats by repeated administration of CCl(4) for 8 weeks. Animals were treated with Aarogyavardhini Vati for various durations. Post treatment of 8 weeks, serum biochemical marker estimations was done. Estimation of mercury and copper from the liver, kidney and brain tissues was done after animal sacrifice. Histopathology evaluation of visceral organs was also performed. RESULTS: Treatment with Aarogyavardhini Vati exhibited significant accumulation of mercury in the kidney but not in the brain and liver. Similarly, no significant accumulation of copper was observed in liver, kidney, and brain due to the treatment of Aarogyavardhini Vati. Serum biochemical and histopathological changes were not affected by the treatment with Aarogyavardhini Vati. CONCLUSION: Aarogyavardhini Vati did not show any biologically significant potential to cause toxicity due to its mercury and copper content when administered for prolonged duration to rats with chronic hepatotoxicity.
format Online
Article
Text
id pubmed-7772489
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77724892020-12-30 Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity Jamadagni, Shrirang Jamadagni, Pallavi Angom, Binita Mondal, Dhirendranath Upadhyay, Sachchidanand Gaidhani, Sudesh Hazra, Jayram J Ayurveda Integr Med Original Research Article (Experimental) BACKGROUND: Aarogyavardhini Vati is a classical Ayurvedic herbomineral formulation. It contains mercury and copper compounds as principal minerals along with other minerals and herbal ingredients. Aarogyavardhini Vati is indicated in chronic liver ailments. However, safety concerns are often raised regarding the use of mercury containing ayurvedic drugs in disease conditions due to the risk of mercury and copper toxicity. OBJECTIVE: This study was performed to address the safety concerns regarding mercury and copper toxicity from Ayurvedic herbomineral formulations by investigating accumulation of these minerals in tissues and subsequent toxicity in chronic hepatotoxicity rat model. MATERIALS AND METHODS: Quantification of mercury and copper in Aarogyavardhini Vati was done. Chronic hepatotoxicity was induced in the Wistar rats by repeated administration of CCl(4) for 8 weeks. Animals were treated with Aarogyavardhini Vati for various durations. Post treatment of 8 weeks, serum biochemical marker estimations was done. Estimation of mercury and copper from the liver, kidney and brain tissues was done after animal sacrifice. Histopathology evaluation of visceral organs was also performed. RESULTS: Treatment with Aarogyavardhini Vati exhibited significant accumulation of mercury in the kidney but not in the brain and liver. Similarly, no significant accumulation of copper was observed in liver, kidney, and brain due to the treatment of Aarogyavardhini Vati. Serum biochemical and histopathological changes were not affected by the treatment with Aarogyavardhini Vati. CONCLUSION: Aarogyavardhini Vati did not show any biologically significant potential to cause toxicity due to its mercury and copper content when administered for prolonged duration to rats with chronic hepatotoxicity. Elsevier 2020 2020-02-05 /pmc/articles/PMC7772489/ /pubmed/32035767 http://dx.doi.org/10.1016/j.jaim.2019.09.005 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article (Experimental)
Jamadagni, Shrirang
Jamadagni, Pallavi
Angom, Binita
Mondal, Dhirendranath
Upadhyay, Sachchidanand
Gaidhani, Sudesh
Hazra, Jayram
Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity
title Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity
title_full Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity
title_fullStr Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity
title_full_unstemmed Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity
title_short Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicity
title_sort tissue distribution of mercury and copper after aarogyavardhini vati treatment in rat model of ccl(4) induced chronic hepatotoxicity
topic Original Research Article (Experimental)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772489/
https://www.ncbi.nlm.nih.gov/pubmed/32035767
http://dx.doi.org/10.1016/j.jaim.2019.09.005
work_keys_str_mv AT jamadagnishrirang tissuedistributionofmercuryandcopperafteraarogyavardhinivatitreatmentinratmodelofccl4inducedchronichepatotoxicity
AT jamadagnipallavi tissuedistributionofmercuryandcopperafteraarogyavardhinivatitreatmentinratmodelofccl4inducedchronichepatotoxicity
AT angombinita tissuedistributionofmercuryandcopperafteraarogyavardhinivatitreatmentinratmodelofccl4inducedchronichepatotoxicity
AT mondaldhirendranath tissuedistributionofmercuryandcopperafteraarogyavardhinivatitreatmentinratmodelofccl4inducedchronichepatotoxicity
AT upadhyaysachchidanand tissuedistributionofmercuryandcopperafteraarogyavardhinivatitreatmentinratmodelofccl4inducedchronichepatotoxicity
AT gaidhanisudesh tissuedistributionofmercuryandcopperafteraarogyavardhinivatitreatmentinratmodelofccl4inducedchronichepatotoxicity
AT hazrajayram tissuedistributionofmercuryandcopperafteraarogyavardhinivatitreatmentinratmodelofccl4inducedchronichepatotoxicity